NOTICIERO VOIDVOID TERMINAL
PRO
Technology

Next-gen ultrasound cancer treatment advances: does the evidence match commercial hype?

Hong Kong is expanding clinical trials of histotripsy, a non-invasive treatment that uses focused ultrasound to destroy tumours, as the city seeks to establish a role in developing the technology for kidney cancer. The CUHK Medical Centre,…

South China Morning Post
Next-gen ultrasound cancer treatment advances: does the evidence match commercial hype?
Image: South China Morning Post

VOID Report: Hong Kong Expands Clinical Trials for Non-Invasive Ultrasound Cancer Treatment

Hong Kong is moving forward with clinical trials for a new cancer treatment called histotripsy, a non-invasive procedure that uses focused ultrasound to destroy tumors. According to the South China Morning Post, the CUHK Medical Centre is involved in the expansion of these trials, specifically for kidney cancer.

The treatment, which is being developed for use in treating kidney cancer, has generated interest in Hong Kong as the city aims to play a role in advancing the technology. The clinical trials are an important step in determining the effectiveness of histotripsy.

The South China Morning Post reports that the technology is being commercialized, but it remains to be seen whether the evidence supports the hype. The Post's article raises questions about the treatment's potential.

Details about the trials, such as the number of participants and the expected duration, have not been reported yet. What readers should watch for is further updates on the trials' progress and findings.

Written with AI by Noticiero VOID from facts reported by South China Morning Post. How we do it ·